Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetic evaluation of capecitabine in breast cancer.
Daniele G, Gallo M, Piccirillo MC, Giordano P, D'Alessio A, Del Giudice A, La Porta ML, Perrone F, Normanno N, De Luca A. Daniele G, et al. Among authors: la porta ml. Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):225-35. doi: 10.1517/17425255.2013.759939. Epub 2013 Jan 10. Expert Opin Drug Metab Toxicol. 2013. PMID: 23301520 Review.
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.
Dalla Costa G, Nos C, Zabalza A, Buron M, Magyari M, Sellebjerg F, Guerrero AI, Roselli L, La Porta ML, Martinis M, Bailon R, Kontaxis S, Laporta E, Garcia E, Pokorny FB, Schuller BW, Folarin A, Stewart C, Leocani L, Vairavan S, Cummins N, Dobson R, Hotopf M, Narayan V, Montalban X, Sorensen PS, Comi G. Dalla Costa G, et al. Among authors: la porta ml. Mult Scler. 2024 Jan;30(1):103-112. doi: 10.1177/13524585231214362. Epub 2023 Dec 12. Mult Scler. 2024. PMID: 38084497
Automatic Assessment of the 2-Minute Walk Distance for Remote Monitoring of People with Multiple Sclerosis.
Kontaxis S, Laporta E, Garcia E, Martinis M, Leocani L, Roselli L, Buron MD, Guerrero AI, Zabala A, Cummins N, Vairavan S, Hotopf M, Dobson RJB, Narayan VA, La Porta ML, Costa GD, Magyari M, Sørensen PS, Nos C, Bailon R, Comi G, On Behalf Of The Radar-Cns Consortium. Kontaxis S, et al. Among authors: la porta ml. Sensors (Basel). 2023 Jun 29;23(13):6017. doi: 10.3390/s23136017. Sensors (Basel). 2023. PMID: 37447866 Free PMC article.
The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies.
Esposito C, Rachiglio AM, La Porta ML, Sacco A, Roma C, Iannaccone A, Tatangelo F, Forgione L, Pasquale R, Barbaro A, Botti G, Ciardiello F, Normanno N. Esposito C, et al. Among authors: la porta ml. Cancer Biol Ther. 2013 Dec;14(12):1143-6. doi: 10.4161/cbt.26340. Epub 2013 Sep 23. Cancer Biol Ther. 2013. PMID: 24025416 Free PMC article.